GP Investments /
Zevia
Zevia agrees $20 million growth equity deal with GP Investments
- Price
- $20 million
- Stage
- Agreement signed
What happened
Zevia, the zero sugar beverage company, has entered into a definitive agreement with a fund managed by GP Investments to issue convertible preferred stock in exchange for $20 million of growth equity.
The investment is structured as Series A Senior Convertible Preferred Stock, convertible into Zevia Class A Common Stock.
Who bought Zevia?
GP Investments agreed to acquire Zevia (Agreement signed, published 22 Oct 2026).
Who is involved, and the source
Everything on this page comes from the source below.
Advisers
Buy side
- Legal adviser to the buyerSkadden, Arps, Slate, Meagher & Flom LLPAdviser profile
Target
- Financial adviser to the targetPiper SandlerAdviser profile
- Legal adviser to the targetRopes & Gray LLPAdviser profile
Advisers are not parties to the deal.
Estimate
$20m Price
Zevia agrees $20 million growth equity deal with GP Investments
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Deal Web
Every firm and person on this deal, and how they connect. Open any name to see their other deals.
Agreement signed · GP Investments agreed to acquire Zevia (Agreement signed, published 22 Oct 2026).
Published 22 Oct 2026- Published by the source
Deal Web as a list
- GP Investments (Buyer) agreed to acquire this deal. GP Investments: 1 deal on Carrywatch.
- Zevia (Target) target this deal. Zevia: 1 deal on Carrywatch.
By email · Weekly